INSIGHTS ON DRUG DEVELOPMENT

• A Human-Relevant Model Of The Liver Sinusoid

  This organ-on-a-chip model minimizes drug absorption while maintaining the essential architecture. Explore the specifications of this product engineered to model the human liver.

• The Next Generation Of Thermal Stability Testing For Biologic Drugs

  Achieving precise measurements in a high-throughput setting can be challenging without disrupting workflows or deadlines. Learn about a new tool for rapid biotherapeutic thermal stability characterization.

• Developing Non-PEG Stabilizer Lipids For Nucleic Acid Lipid Nanoparticles

  Non-PEG stabilizer lipids may offer a new path for LNP design. Combining strong colloidal performance with greater chemical flexibility helps address growing concerns around PEG-related immunogenicity.

• Increase Throughput For Intact Mass Confirmation And Impurity Screening

  Accelerate intact mass analysis of GLP-1 analogues with automated purity calculations, sub-ppm mass accuracy, and impurity detection for consistent results in under one minute per sample.

• Modifying The Micro-Environment To Improve Dissolution Rate

  6/11/2025

  Discover how modifying the micro-environment with targeted excipients can significantly enhance the dissolution rate of poorly soluble drugs using conventional manufacturing methods.

• Tablet Manufacturing Technologies For Solid Drug Formulation

  4/2/2025

  Compressed tablets are common oral solid dosages that contain the API and various excipients. Learn about the critical steps in selecting manufacturing methods and excipients to achieve the desired therapeutic effects and stability.

• How One Biotech Company Is Accelerating The Drug Discovery Workflow

  11/14/2025

  See how biotech innovation is accelerating drug discovery through AI, miniaturized workflows, and collaborative technologies to reshape how therapies are developed and delivered.

• Take The Wheel And Drive Your Oligo Synthesis Where You Want

  2/9/2026

  Explore the evolving oligo therapeutic landscape while identifying common challenges of bringing production in‑house and the key factors that shape long‑term success for smoother scale‑up.

• Considerations In Design And Development Of Novel Combination Drug-Delivery Devices

  7/17/2026

  Poor scoping kills drug delivery device programs before they start. Learn how to define the right problem, assess risk early, and set boundaries that protect your timeline and budget.